Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), Subcommittee on Procedures Review (SPR), National Institute for Occupational Safety and Health (NIOSH), 92818-92819 [2016-30520]

Download as PDF 92818 Federal Register / Vol. 81, No. 244 / Tuesday, December 20, 2016 / Notices Reporting—Hospital, Version 1.2, as a starting point. AHRQ, in conjunction with community pharmacy representatives, designed these new formats to facilitate improved detection and understanding of medicationrelated events originating in pharmacies. If implemented as specified, the Common Formats— Community Pharmacy Version 1.0 will allow aggregation of medication-related data across different pharmacy providers. On October 6, 2015, AHRQ announced the availability of the— Common Formats Retail Pharmacy Version 0.1 Beta—for review and comment in the Federal Register (80 FR 60385–60387). After obtaining feedback from both the private and public sectors, the Agency finalized the format and renamed it Common Formats— Community Pharmacy Version 1.0. All elements—including the event description, aggregate reports, data elements and algorithms, and technical specifications—will be posted at the PSOPPC Web site: https:// www.psoppc.org/psoppc_web. More information on the Common Formats can be obtained through AHRQ’s PSO Web site: https:// www.pso.ahrq.gov/. Sharon B. Arnold, Deputy Director. [FR Doc. 2016–30604 Filed 12–19–16; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on DSK3G9T082PROD with NOTICES Mine Safety and Health Research Advisory Committee: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Mine Safety and Health Research Advisory Committee, Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through November 30, 2018. For information, contact Jeffrey H. Welsh, B.A., Designated Federal Officer, Mine Safety and Health Research Advisory Committee, Centers for Disease Control and Prevention, Department of Health and Human Services, 626 Cochrans Mill Road, Mailstop P05, Pittsburgh, Pennsylvania 15236, Telephone (412) 386–4040 or fax (412) 386–6614. VerDate Sep<11>2014 19:36 Dec 19, 2016 Jkt 241001 The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–30525 Filed 12–19–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), Subcommittee on Procedures Review (SPR), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting for the aforementioned subcommittee: Time and Date: 11:00 a.m.–4:30 p.m., EST, January 10, 2017 Place: Audio Conference Call via FTS Conferencing. Status: Open to the public, but without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference at the USA toll-free, dial-in number at 1–866–659– 0537 and the pass code is 9933701. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered on March 22, 2016, pursuant to Executive Order 13708, and will expire on September 30, 2017. Purpose: The Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. SPR was established to aid the Advisory Board in carrying out its duty to advise the Secretary, HHS, on dose reconstruction. SPR is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Division of Compensation Analysis and Support (DCAS) and its dose reconstruction contractor (Oak Ridge Associated Universities—ORAU). Matters for Discussion: The agenda for the Subcommittee meeting includes: discussion of procedures in the following ORAU and DCAS technical documents: OCAS Technical Information Bulletin (TIB) 0013 and ORAUT Procedure 0042 (‘‘Individual Dose Adjustment Procedure for Y–12 Dose Reconstruction’’ and ‘‘Accounting for Incomplete Personal Monitoring Data on Penetrating Gamma-Ray Doses to Workers in Radiation Areas at the Oak Ridge Y–12 Plant Prior to 1961’’); Program Evaluation Report OCAS–PER– 011, (‘‘K–25 TBD and TIB Revisions’’), PER–055 (‘‘TBD 6000 Revisions’’), PER– 057 (‘‘General Steel Industries’’), PER 60 (‘‘Blockson Chemical Company’’), PER– 064 (‘‘DuPont Deep Water Works’’), and PER–066 (‘‘Huntington Pilot Plant’’), and a continuation of the commentresolution process for other dose E:\FR\FM\20DEN1.SGM 20DEN1 Federal Register / Vol. 81, No. 244 / Tuesday, December 20, 2016 / Notices reconstruction procedures under review by the Subcommittee. The agenda is subject to change as priorities dictate. Contact Person for More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta, Georgia 30333, Telephone (513)533–6800, Toll Free 1(800) CDC–INFO, Email ocas@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. 2016–30520 Filed 12–19–16; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on DSK3G9T082PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) PAR15–352, Occupational Safety and Health Training Projects. SUMMARY: This publication corrects a notice that was published in the Federal Register on December 6, 2016, 2016 Volume 81, Number 234, pages 87938– 87939. The dates should read as follows: 1:00 p.m.–6:00 p.m., EST, January 18, 2017 (Closed) 1:00 p.m.–6:00 p.m., EST, January 19, 2017 (Closed) CONTACT PERSON FOR MORE INFORMATION: Nina L. Turner, Ph.D., Scientific Review Officer, CDC, 1095 Willowdale Road, Mailstop L1055, Morgantown, WV Telephone: (304) 285–6047, NTURNER@CDC.GOV. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Sep<11>2014 19:36 Dec 19, 2016 Jkt 241001 Prevention and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–30518 Filed 12–19–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), Subcommittee for Dose Reconstruction Reviews (SDRR), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting for the aforementioned subcommittee: Time and Date: 10:30 a.m.–5:00 p.m., EST, January 30, 2017. Place: Audio Conference Call via FTS Conferencing. Status: Open to the public, but without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference at the USA toll-free, dial-in number at 1–866–659– 0537 and the pass code is 9933701. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 92819 In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered on March 22, 2016 pursuant to Executive Order 13708, and will expire on September 30, 2017. Purpose: The Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. The Subcommittee for Dose Reconstruction Reviews was established to aid the Advisory Board in carrying out its duty to advise the Secretary, HHS, on dose reconstruction. Matters for Discussion: The agenda for the Subcommittee meeting includes the following dose reconstruction program quality management and assurance activities: dose reconstruction cases under review from Sets 14–23, including the Oak Ridge sites (Y–12, K– 25, Oak Ridge National Laboratory), Hanford, Feed Materials Production Center (‘‘Fernald’’), Mound Plant, Rocky Flats Plant, Nevada Test Site, Idaho National Laboratory, Savannah River Site, and other facilities. The agenda is subject to change as priorities dictate. Contact Person for More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta, Georgia 30329, Telephone (513)533–6800, Toll Free 1(800)CDC–INFO, Email ocas@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and E:\FR\FM\20DEN1.SGM 20DEN1

Agencies

[Federal Register Volume 81, Number 244 (Tuesday, December 20, 2016)]
[Notices]
[Pages 92818-92819]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30520]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Board on Radiation and Worker Health (ABRWH or the 
Advisory Board), Subcommittee on Procedures Review (SPR), National 
Institute for Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting for the 
aforementioned subcommittee:
    Time and Date: 11:00 a.m.-4:30 p.m., EST, January 10, 2017
    Place: Audio Conference Call via FTS Conferencing.
    Status: Open to the public, but without a public comment period. 
The public is welcome to submit written comments in advance of the 
meeting, to the contact person below. Written comments received in 
advance of the meeting will be included in the official record of the 
meeting. The public is also welcome to listen to the meeting by joining 
the teleconference at the USA toll-free, dial-in number at 1-866-659-
0537 and the pass code is 9933701.
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include providing advice 
on the development of probability of causation guidelines that have 
been promulgated by the Department of Health and Human Services (HHS) 
as a final rule; advice on methods of dose reconstruction, which have 
also been promulgated by HHS as a final rule; advice on the scientific 
validity and quality of dose estimation and reconstruction efforts 
being performed for purposes of the compensation program; and advice on 
petitions to add classes of workers to the Special Exposure Cohort 
(SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, rechartered on March 22, 2016, 
pursuant to Executive Order 13708, and will expire on September 30, 
2017.
    Purpose: The Advisory Board is charged with (a) providing advice to 
the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advise the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class. SPR was 
established to aid the Advisory Board in carrying out its duty to 
advise the Secretary, HHS, on dose reconstruction. SPR is responsible 
for overseeing, tracking, and participating in the reviews of all 
procedures used in the dose reconstruction process by the NIOSH 
Division of Compensation Analysis and Support (DCAS) and its dose 
reconstruction contractor (Oak Ridge Associated Universities--ORAU).
    Matters for Discussion: The agenda for the Subcommittee meeting 
includes: discussion of procedures in the following ORAU and DCAS 
technical documents:
    OCAS Technical Information Bulletin (TIB) 0013 and ORAUT Procedure 
0042 (``Individual Dose Adjustment Procedure for Y-12 Dose 
Reconstruction'' and ``Accounting for Incomplete Personal Monitoring 
Data on Penetrating Gamma-Ray Doses to Workers in Radiation Areas at 
the Oak Ridge Y-12 Plant Prior to 1961''); Program Evaluation Report 
OCAS-PER-011, (``K-25 TBD and TIB Revisions''), PER-055 (``TBD 6000 
Revisions''), PER-057 (``General Steel Industries''), PER 60 
(``Blockson Chemical Company''), PER-064 (``DuPont Deep Water Works''), 
and PER-066 (``Huntington Pilot Plant''), and a continuation of the 
comment-resolution process for other dose

[[Page 92819]]

reconstruction procedures under review by the Subcommittee.
    The agenda is subject to change as priorities dictate.
    Contact Person for More Information: Theodore Katz, Designated 
Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta, 
Georgia 30333, Telephone (513)533-6800, Toll Free 1(800) CDC-INFO, 
Email ocas@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office Centers for 
Disease Control and Prevention.
[FR Doc. 2016-30520 Filed 12-19-16; 8:45 am]
 BILLING CODE 4163-19-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.